
Hong Kong biotech enters its second act with a licensing supercycle
As summer arrives, the rally in Hong Kong-listed biotech stocks is still going strong. In the first half of the year, companies like Harbour BioMed (HBM), Jacobio Pharmaceuticals, and 3SBio saw their share prices more than triple, with several others at …